Safety of renal biopsy bleeding prophylaxis with desmopressin
Background Percutaneous renal biopsy (PRB) is invasive, and bleeding-related complications are a concern. Desmopressin (DDAVP) is a selective type 2 vasopressin receptor-agonist also used for haemostasis. Aim To evaluate the side effects of intravenous (IV) weight-adjusted desmopressin preceding PRB...
Main Authors: | R. Haridian Sosa Barrios, Víctor Burguera Vion, Marta Álvarez Nadal, Melissa Cintra Cabrera, Sandra Elías Triviño, Daniel Villa Hurtado, Sofía Ortego, Milagros Fernández Lucas, Maite Rivera-Gorrin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211040764 |
Similar Items
-
Percutaneous Renal Biopsy Prescreen Prior to Procedure
by: R. Haridian Sosa Barrios, et al.
Published: (2020-05-01) -
Desmopressin and bleeding risk after percutaneous kidney biopsy
by: Ambarish Athavale, et al.
Published: (2019-11-01) -
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
by: Marta Alvarez Nadal, et al.
Published: (2020-09-01) -
Megacalycosis: Sonographic findings of a rare clinical condition
by: Rosa Haridian Sosa Barrios, et al.
Published: (2021-02-01) -
Arteriovenous fistulae after renal biopsy: diagnosis and outcomes using Doppler ultrasound assessment
by: R. Haridian Sosa-Barrios, et al.
Published: (2017-12-01)